CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Open-Label, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Intracerebroventricular BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02678689
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:50.835134+00:00
Published At: 2025-02-17T00:00:00+00:00
Record Updated At: 2025-02-17
Results Posted At: 2025-02-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Jansky-Bielschowsky Disease", "Batten Disease", "Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2", "CLN2 Disease", "CLN2 Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-17"
protocolSection.identificationModule.nctId: "NCT02678689"
protocolSection.identificationModule.officialTitle: "A Phase 2, Open-Label, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Intracerebroventricular BMN 190 in Pediatric Patients \u003c 18 Years of Age With CLN2 Disease"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-02-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.